Status:
COMPLETED
Steroid Injection Treatment of Carpal Tunnel Syndrome
Lead Sponsor:
Region Skane
Conditions:
Carpal Tunnel Syndrome
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
PHASE3
Brief Summary
The aim of this study is to assess the efficacy of injecting steroid into the carpal tunnel in relieving symptoms of carpal tunnel syndrome for at least 1 year with outcomes measured with patient eval...
Detailed Description
www.biomedcentral.com/1471-2474/11/76
Eligibility Criteria
Inclusion
- Primary, idiopathic CTS
- Age 18-70 years, either gender
- Symptom duration of at least 3 months and inadequate response to wrist splint
- Symptoms of classic or probable CTS according to the diagnostic criteria in Katz hand diagram
- Nerve conduction studies showing median neuropathy at the wrist and no other abnormalities or, in the absence of abnormal nerve conduction study results, 2 surgeons should independently diagnose the patient with CTS.
- Scheduled for carpal tunnel release (ie, symptom severity indicating need for surgery)exclusion criteria
Exclusion
- Previous steroid injection for CTS in the same wrist
- Inflammatory joint disease, diabetes mellitus· Vibration-induced neuropathy, polyneuropathy
- Pregnancy
- Trauma to the affected hand in the previous year
- Previous CTS surgery in the affected hand
- Inability to complete questionnaires due to language problem or cognitive disorder
- Severe medical illness
- Known abuse of drugs and/or alcohol
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2012
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT00806871
Start Date
November 1 2008
End Date
April 1 2012
Last Update
April 4 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ortopediska kliniken, sjukvårdsorganisationen Hässleholm/CSK
Hässleholm, Sweden, 281 25